Published in Fam Pract on November 27, 2008
Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in overweight and obese people. Cochrane Database Syst Rev (2010) 1.61
General practitioners' and district nurses' conceptions of the encounter with obese patients in primary health care. BMC Fam Pract (2011) 0.91
Educating the clinical trainer: professional gain for the trainee? A controlled intervention study in general practice. Perspect Med Educ (2014) 0.84
Management of Overweight during Childhood: A Focus Group Study on Health Professionals' Experiences in General Practice. Int J Family Med (2015) 0.75
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet (2006) 6.50
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med (2003) 5.83
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med (2002) 5.55
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med (2010) 4.52
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol (2006) 3.31
Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract (2008) 3.16
Childhood IQ, social class, deprivation, and their relationships with mortality and morbidity risk in later life: prospective observational study linking the Scottish Mental Survey 1932 and the Midspan studies. Psychosom Med (2003) 2.69
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. Eur Heart J (2007) 2.56
Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med (2003) 2.56
The impact of obesity on drug prescribing in primary care. Br J Gen Pract (2005) 2.56
A cluster randomised controlled trial of vascular risk factor management in general practice. Med J Aust (2012) 2.53
Childhood mental ability and blood pressure at midlife: linking the Scottish Mental Survey 1932 and the Midspan studies. J Hypertens (2004) 2.13
Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones. Obes Surg (2014) 2.01
Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut (2013) 2.01
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.97
A new evidence-based model for weight management in primary care: the Counterweight Programme. J Hum Nutr Diet (2004) 1.97
Reverse causality and confounding and the associations of overweight and obesity with mortality. Obesity (Silver Spring) (2006) 1.89
Long-term cost-effectiveness of weight management in primary care. Int J Clin Pract (2010) 1.81
Reference ranges still need further clarity. Ann Clin Biochem (2009) 1.80
Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism (2011) 1.79
Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents. Clin Endocrinol (Oxf) (2012) 1.77
Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J Am Coll Cardiol (2007) 1.77
Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis (2008) 1.76
Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem (2002) 1.61
Management of obesity in adults: European clinical practice guidelines. Obes Facts (2008) 1.59
Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation. Clin Chem Lab Med (2013) 1.58
Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance. Cell Metab (2006) 1.57
Empowering primary care to tackle the obesity epidemic: the Counterweight Programme. Eur J Clin Nutr (2005) 1.57
Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab (2002) 1.56
Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol (Oxf) (2002) 1.55
Role of resistin in obesity, insulin resistance and Type II diabetes. Clin Sci (Lond) (2005) 1.55
Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet (2002) 1.53
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes (2005) 1.52
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology (2005) 1.49
Detection of patients with acute kidney injury by the clinical laboratory using rises in serum creatinine: comparison of proposed definitions and a laboratory delta check. Ann Clin Biochem (2011) 1.49
Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes (2006) 1.46
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod (2005) 1.43
High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care (2011) 1.43
Current approaches to obesity management in UK Primary Care: the Counterweight Programme. J Hum Nutr Diet (2004) 1.43
Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer (2009) 1.42
Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab (2003) 1.42
Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial. Diabetes Care (2013) 1.41
Glycemic control in the 12 months following a change to SI hemoglobin A1c reporting units. Clin Chem (2013) 1.40
The 45 year old health check - feasibility and impact on practices and patient behaviour. Aust Fam Physician (2009) 1.40
Biochemical endocrinology of the hypogonadal male. Ann Clin Biochem (2010) 1.40
Standardization of glycated haemoglobin. Ann Clin Biochem (2002) 1.39
Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr (2010) 1.39
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens (2012) 1.37
Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab (2003) 1.35
Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab (2007) 1.35
Validation of a quantitative magnetic resonance method for measuring human body composition. Obesity (Silver Spring) (2008) 1.34
The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) (2011) 1.33
Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis (2006) 1.32
Outcome following surgery for colorectal cancer. Br Med Bull (2002) 1.29
The Midspan studies. Int J Epidemiol (2005) 1.29
Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol (2010) 1.27
Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes. Diabetes Care (2007) 1.27
Resistin. Curr Opin Lipidol (2006) 1.25
Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol (2009) 1.22
Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care (2008) 1.17
Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations. Pituitary (2014) 1.16
Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. Eur J Endocrinol (2010) 1.16
Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol (2012) 1.14
Obesity impacts on general practice appointments. Obes Res (2005) 1.14
Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia. Diabetes (2012) 1.13
Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J (2007) 1.12
Parent-offspring transmission of adipocytokine levels and their associations with metabolic traits. PLoS One (2011) 1.10
Harmonization of quality indicators in laboratory medicine. A preliminary consensus. Clin Chem Lab Med (2014) 1.09
Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study. Circ Cardiovasc Genet (2010) 1.09
Acute ingestion of resistant starch reduces food intake in healthy adults. Br J Nutr (2009) 1.09
Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. Circulation (2005) 1.08
Effect of conjugal bereavement on mortality of the bereaved spouse in participants of the Renfrew/Paisley Study. J Epidemiol Community Health (2007) 1.08
The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod (2006) 1.08
Children's residential weight-loss programs can work: a prospective cohort study of short-term outcomes for overweight and obese children. Pediatrics (2005) 1.07
Health improvement and prevention study (HIPS) - evaluation of an intervention to prevent vascular disease in general practice. BMC Fam Pract (2010) 1.07
Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes (2002) 1.07
Sleep duration and quality associated with obesity among Arab children. Obesity (Silver Spring) (2009) 1.06
Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study. Crit Care (2006) 1.05
Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care. J Health Serv Res Policy (2008) 1.05
Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity. Br J Gen Pract (2013) 1.04
Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population. BMC Med Genet (2008) 1.04
Premature cardiovascular events and mortality in south Asians with type 2 diabetes in the United Kingdom Asian Diabetes Study - effect of ethnicity on risk. Curr Med Res Opin (2010) 1.03
The beneficial effect of a diet with low glycaemic index on 24 h glucose profiles in healthy young people as assessed by continuous glucose monitoring. Br J Nutr (2005) 1.03
Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol (2006) 1.02
Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes. Diabetes Care (2004) 1.01
The effect of dietary glycemic index on weight maintenance in overweight subjects: a pilot study. Obesity (Silver Spring) (2008) 1.01
A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men. Br J Nutr (2003) 1.01
Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes. PLoS One (2011) 1.01
Does knowledge of cancer diagnosis affect quality of life? A methodological challenge. BMC Cancer (2004) 1.00
Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice. Clin Chem (2005) 1.00
Predictors of primary care referrals to a vascular disease prevention lifestyle program among participants in a cluster randomised trial. BMC Health Serv Res (2012) 0.99
Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovasc Diabetol (2013) 0.98
What is the evidence for gender differences in ferritin and haemoglobin? Crit Rev Oncol Hematol (2010) 0.97
Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS One (2013) 0.97
Randomised controlled feasibility trial of a web-based weight management intervention with nurse support for obese patients in primary care. Int J Behav Nutr Phys Act (2014) 0.97
Lipopolysaccharide, high glucose and saturated fatty acids induce endoplasmic reticulum stress in cultured primary human adipocytes: Salicylate alleviates this stress. Biochem Biophys Res Commun (2010) 0.97
Body mass index in middle life and future risk of hospital admission for psychoses or depression: findings from the Renfrew/Paisley study. Psychol Med (2007) 0.97
The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes. J Clin Endocrinol Metab (2006) 0.97
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. Metabolism (2009) 0.97